The Daily Signal: The problem of Post-SSRI Sexual Dysfunction

The Daily Signal discusses the importance of Post-SSRI Sexual Dysfunction (PSSD) and elaborates that new patients need to be warned regardless of the risk. This article acknowledges the dismissal of most doctors, despite increasing recognition. One thing this article misses though, is that it claims PSSD is formally recognized. PSSD is not recognized in the US, and the FDA has not added this to side effect labels as of 2026.

Previous
Previous

PolitiFact: What we know about sexual function after antidepressants

Next
Next

ReachLink: What nobody tells you about Antidepressants and PSSD